Related Experiment Videos
Coronary atherosclerosis and interventions: pathological sequences and restenosis
C Yutani1, M Imakita, H Ishibashi-Ueda
1Department of Pathology, National Cardiovascular Center, Suita, Osaka, Japan. cyutani@hsp.ncvc.go.jp
Pathology International
|June 12, 1999
Summary
Atherosclerosis, a leading cause of heart disease, involves plaque rupture influenced by composition, not just size. Restenosis after stenting involves vascular remodeling and intimal hyperplasia.
Area of Science:
- Cardiovascular Pathology
- Interventional Cardiology
Background:
- Ischemic heart disease, primarily caused by atherosclerosis, is a major cause of death globally.
- Atherosclerosis involves complex lesion development, with Stary's classification offering detailed morphological and biochemical insights.
- Acute coronary syndrome is often linked to the rupture of vulnerable atherosclerotic plaques.
Purpose of the Study:
- To clarify the mechanisms of atherosclerotic plaque disruption.
- To elucidate the relationship between plaque disruption and coronary risk factors in elderly Japanese patients with acute coronary syndrome.
- To describe the pathological mechanisms of restenosis following percutaneous transluminal coronary angioplasty (PTCA) and/or stent placement.
Main Methods:
- Utilized advanced imaging techniques like angioscopy and intravascular ultrasound.
- Analyzed autopsy studies of restenosis post-PTCA.
- Investigated the effect of tissue factor pathway inhibitor on interventional restenosis.
Main Results:
- Plaque composition, particularly high content of soft extracellular lipids and macrophages, increases vulnerability to rupture.
- Adventitial scarring and remodeling are identified as major contributors to restenosis after PTCA.
- Late in-stent restenosis remains a limitation, influenced by stent design and patient factors.
Conclusions:
- Understanding plaque composition is crucial for managing acute coronary syndrome.
- Adventitial remodeling and intimal hyperplasia are key pathological mechanisms of restenosis.
- Further research into interventions like tissue factor pathway inhibitors may help prevent restenosis.